SGRY vs AMSF vs KNTK vs USPH

For growth investors, Kinetik Holdings Inc.

(KNTK) is the stronger pick with 19. 0% revenue growth year-over-year, versus 2. 6% for AMERISAFE, Inc. (AMSF). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Surgery Partners, Inc. (SGRY) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, AMERISAFE, Inc.

(AMSF) is the cheapest at 12. 3x versus U. S. Physical Therapy, Inc. at 41. 5x. On forward P/E, AMERISAFE, Inc. is actually cheaper at 14. 4x.

Over the past 5 years, Kinetik Holdings Inc.

(KNTK) delivered a total return of +93. 1%, compared to -72. 3% for Surgery Partners, Inc. (SGRY). Over 10 years, the gap is even starker: AMSF returned +31. 8% versus KNTK's -33. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), AMERISAFE, Inc.

(AMSF) is the lower-risk stock at 0. 23β versus Surgery Partners, Inc. 's 1. 04β — meaning SGRY is approximately 352% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 132% for Kinetik Holdings Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Kinetik Holdings Inc.

(KNTK) is pulling ahead at 19. 0% versus 2. 6% for AMERISAFE, Inc. (AMSF). On earnings-per-share growth, the picture is similar: Kinetik Holdings Inc. grew EPS 157. 8% year-over-year, compared to -22. 8% for U. S. Physical Therapy, Inc.. Over a 3-year CAGR, KNTK leads at 13. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

AMERISAFE, Inc.

(AMSF) is the more profitable company, earning 14. 9% net margin versus -2. 4% for Surgery Partners, Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus 9. 3% for KNTK. At the gross margin level — before operating expenses — AMSF leads at 46. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, AMERISAFE, Inc.

(AMSF) trades at 14. 4x forward P/E versus 42. 4x for Kinetik Holdings Inc. — 28. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USPH: 72. 9% to $102. 00.

In this comparison, KNTK (16.

5% yield), AMSF (8. 4% yield), USPH (3. 1% yield) pay a dividend. SGRY does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, AMERISAFE, Inc.

(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 4% yield). Both have compounded well over 10 years (AMSF: +31. 8%, SGRY: -0. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SGRY (Healthcare) and AMSF (Financial Services) and KNTK (Energy) and USPH (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SGRY is a small-cap quality compounder stock; AMSF is a small-cap deep-value stock; KNTK is a small-cap high-growth stock; USPH is a small-cap high-growth stock. AMSF, KNTK, USPH pay a dividend while SGRY does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.